Abstract
In the UK, the Administration of Radioactive Substances Advisory Committee (ARSAC) sets and publishes National Diagnostic Reference Levels (NDRLs) for diagnostic nuclear medicine (NM) and Positron Emission Tomography procedures. This article summarises how these NDRLs should be applied and used within the UK and proposes a new model on how they are set. As an exemplar, the results of a recent survey of administered activities in the UK for 18F-fluorodeoxyglucose (FDG) for whole-body tumour imaging and infection inflammation imaging are presented here. ARSAC recommends that the UK NDRLs for NM or PET examinations are set as either a fixed activity (MBq) or by administered activity per body weight (MBq/ kg). ARSAC proposes setting the first weight-based activity scaling NDRLs for 18F-FDG whole-body tumour imaging and 18F-FDG infection inflammation imaging to 3.5 MBq/ kg.
| Original language | English |
|---|---|
| Pages (from-to) | 379-383 |
| Number of pages | 5 |
| Journal | Nuclear Medicine Communications |
| Volume | 46 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 5 Feb 2025 |
Bibliographical note
Publisher Copyright:Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Keywords
- PET
- administered activity
- diagnostic reference levels
- nuclear medicine
- optimisation